Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Abcellera Biologics Inc
(NQ:
ABCL
)
2.610
-0.010 (-0.38%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Abcellera Biologics Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
AbCellera Presents New Data on T-Cell Engager Platform at AACR 2023
April 17, 2023
From
AbCellera Biologics Inc.
Via
Business Wire
1 Sector Received $6.1 Billion in AI Investments Last Year: 3 Top Stocks to Buy
April 13, 2023
These companies are leading the way in using AI in healthcare.
Via
The Motley Fool
7 Best Stocks Under $10 to Buy in April
April 11, 2023
Although these stocks under $10 to buy may be cheap, their underlying businesses could yield significant upside.
Via
InvestorPlace
AbCellera to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference on April 25, 2023
April 11, 2023
From
AbCellera Biologics Inc.
Via
Business Wire
4 Analysts Have This to Say About AbCellera Biologics
February 28, 2023
Via
Benzinga
Preview: AbCellera Biologics's Earnings
February 20, 2023
Via
Benzinga
AbCellera to Report First Quarter 2023 Financial Results on May 4, 2023
April 06, 2023
From
AbCellera Biologics Inc.
Via
Business Wire
7 Thrilling Biotech Stocks for Aggressive Investors to Buy
April 05, 2023
Amid the noise of the global markets recently, these speculative biotech stocks to buy might trade with a mind of their own.
Via
InvestorPlace
7 Stocks to Bet On if You Want to Be Richer Than Elon Musk
March 22, 2023
If you can handle the heat of extreme speculation, you may want to throw some gambling funds at these stocks that can make you rich.
Via
InvestorPlace
AbCellera and RQ Bio Partner to Accelerate the Advancement of New Therapies for Infectious Disease
March 22, 2023
From
AbCellera Biologics Inc.
Via
Business Wire
The Latest Analyst Ratings for AbCellera Biologics
January 06, 2023
Via
Benzinga
AbCellera Announces Two Presentations on T-Cell Engager Discovery at AACR 2023
March 14, 2023
From
AbCellera Biologics Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For February 28, 2023
February 28, 2023
Via
Benzinga
AbCellera to Present at the Cowen 43rd Annual Health Care Conference on March 6, 2023
February 23, 2023
From
AbCellera Biologics Inc.
Via
Business Wire
AbCellera Biologics (ABCL) Q4 2022 Earnings Call Transcript
February 21, 2023
ABCL earnings call for the period ending December 31, 2022.
Via
The Motley Fool
AbCellera Reports Full Year 2022 Business Results
February 21, 2023
From
AbCellera Biologics Inc.
Via
Business Wire
The 7 Most Undervalued Biotech Stocks to Buy in February 2023
February 02, 2023
Get your hands on the latest medical innovations at a compelling discount with the most undervalued biotech stocks to buy.
Via
InvestorPlace
AbCellera to Present at the SVB Securities Global Biopharma Conference on February 15, 2023
February 01, 2023
From
AbCellera Biologics Inc.
Via
Business Wire
AbCellera to Report Full Year 2022 Financial Results on February 21, 2023
January 24, 2023
From
AbCellera Biologics Inc.
Via
Business Wire
AbCellera Announces that the U.S. Patent Trial and Appeal Board Upholds Microfluidic Cell Culture Patent
January 19, 2023
From
AbCellera Biologics Inc.
Via
Business Wire
AbCellera to Present at the 41st Annual J.P. Morgan Healthcare Conference on January 11, 2023
January 04, 2023
From
AbCellera Biologics Inc.
Via
Business Wire
RCI Hospitality, AbCellera Biologics And Some Other Big Stocks Moving Higher On Thursday
December 15, 2022
U.S. stocks traded lower, with the Dow Jones dropping over 600 points on Thursday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
AbCellera and AbbVie Partner to Advance New Antibody Therapies
December 15, 2022
From
AbCellera Biologics Inc.
Via
Business Wire
Why Planet Labs Shares Are Trading Higher; Here Are 28 Stocks Moving Premarket
December 15, 2022
Gainers Scopus BioPharma Inc. (NASDAQ: SCPS) shares rose 74.7% to $0.4104 in pre-market trading after declining 4% on Wednesday.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2022
December 15, 2022
Via
Benzinga
Why Quotient Shares Are Trading Lower By More Than 48%; Here Are 37 Stocks Moving Premarket
December 13, 2022
Gainers Netcapital Inc. (NASDAQ: NCPL) shares rose 91.3% to $2.65 in pre-market trading following Q2 results. Netcapital posted Q2 earnings of $0.04 per share on sales of $1.78 million.
Via
Benzinga
Pinterest, Oracle And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
December 13, 2022
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. ACM Research, Inc. (NASDAQ: ACMR) shares jumped 25.9% to $10.98 in...
Via
Benzinga
AbCellera and Rallybio Announce Strategic Alliance to Discover, Develop, and Commercialize Novel Antibody-Based Therapeutics for Rare Diseases
December 01, 2022
From
Rallybio Corporation
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For November 16, 2022
November 16, 2022
Upgrades
Via
Benzinga
Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday
November 11, 2022
Gainers
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.